Biological Activity
Atrasentan is an experimental drug that is being studied for the treatment of various types of cancer, including non-small cell lung cancer. It is an endothelin receptor antagonist selective for subtype A (ETA).
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.58 mL | 97.92 mL | 195.84 mL |
0.5 mM | 3.92 mL | 19.58 mL | 39.17 mL |
1 mM | 1.96 mL | 9.79 mL | 19.58 mL |
5 mM | 0.39 mL | 1.96 mL | 3.92 mL |
*The above data is based on the productmolecular weight 510.62. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A13779 |
---|---|
Actions | Antagonist |
CAS No. | 173937-91-2 |
Formula | C29H38N2O6 |
M. Wt | 510.62 |
Purity | >98% |
Synonyms | (+)-A 127722, ABT-627, A 127722, ABT 627 |
SMILES | CCCCN(CCCC)C(=O)CN1C[[email protected]@H]([[email protected]]([[email protected]@H]1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy Atrasentan | Atrasentan Supplier | purchase | cost | manufacturer | order | distributor | buy 173937-91-2| 173937-91-2 Supplier | purchase 173937-91-2 | 173937-91-2 cost | 173937-91-2 manufacturer | order 173937-91-2 | 173937-91-2 distributor